Please login to the form below

Not currently logged in
Email:
Password:

PR and Med Ed news in brief

Our weekly round up of healthcare PR stories

J&J linked with Olympic sponsorship deal

Speculation is mounting that Johnson & Johnson is set to become a top-tier sponsor of the Olympic Games. The US pharma company is expected to sign a £100m deal with the International Olympic Committee after the completion of the 2006 Winter Games in Turin next February. The deal would allow J&J to use the famous Olympic Rings trademark across all its products and have an exclusive presence at future Games up until at least the London Games in 2012.

Galliard wins GSK Avodart contract

Galliard Healthcare Communications has won the global PR contract for GlaxoSmithKline's (GSK) benign prostatic hyperplasia treatment Avodart. The London-based agency beat off competition from Edelman and Ketchum to replace Fleishman-Hillard, which declined to repitch for the account citing a conflict of interest. Galliard managing director Marika Freris will lead a four-strong team on the account, reporting to GSK's global scientific communications strategy team. GSK is currently investigating Avodart's use in the prevention of prostate cancer, a potentially lucrative market if it succeeds in clinical trials.

2nd September 2008

Share

] [PR and Med Ed news in brief, Our weekly round up of healthcare PR stories, News Article, , ,] -->

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics